Navigation Links
Reportlinker Adds Indian Bulk Drug Market

NEW YORK, Oct. 21 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Indian Bulk Drug Market

Indian bulk drug industry to grow to US$ 17 billion by 2014

Indian Bulk Drug industry is expected to grow at a CAGR of 21% to reach US$16.91 billion by 2013-14 as per a Cygnus study. Cygnus estimates the size of Indian bulk drug industry for 2009-10 at US$ 11.54 billion, out of which exports contribute about US$ 7.5 billion, constituting 65% of the industry. Indian Contract Manufacturing market stood at US$986m in 2009 and is expected to grow at a CAGR of 41.7% to reach US$5.63 billion by 2014.

India has the highest number of Drug Master Filings (DMF) amongst all key competing economies. From 2000-2008 India had more than 1614 filings, 3 times higher than that of China. Other Countries such as Italy, Spain, Mexico, Brazil etc are far behind as compare to India. The share of Drug Master Filings made by Indian firms has increased considerably from 14% in 2000 to 50% in 2009.

In view of the significant growth potential of Indian bulk drugs industry, Cygnus releases the latest version of the Indian Bulk Drugs Industry Insight. The report will be useful to senior executives associated with the industry, bankers, private equity players, investors, students, research scholars and industry analysts who need relevant industry inputs for their work.


• Global and Indian Bulk Drug Market

• Key Growth Drivers

• Industry Regulations

• Issues & Challenges

• Major Players – Business profile, Their Bulk Actives therapeutic segment wise, Strategies, M& A / Alliances, Financial Profile, SWOT Analysis and Future Outlook.

• Major Medical Institutes

• Critical Success Factors

• Future outlook


• Major therapeutic categories and Annual Production of Major Bulk Drugs

• Major Deals Announced/Completed By Indian Companies

• Drug Patent Expirations

• ANDA Filings by Indian Companies

• R&D Expenditure

• DMF filings by Indian companies

• India's Advantages for Contract Manufacturing

• A Comparison between India and China

• 320 DMF filings by Indian companies

• List of Bulk Drugs Manufacturers in India


• Latest and Very Comprehensive report on Indian API Market

• Gives insights into Indian Pharma industry also along with the outsourcing market

• Lists of various sought after Data such as patent expirations, DMF, import - export etc


Indian Pharmaceutical Markets, Quarterly Update & Analysis on Indian Pharma, Indian Dental Market, Clinical Trials in India, CRAMS Market


1. Executive Summary

2. Highlights

3. Global Bulk drugs Market --- Market Overview

3.1. Introduction

3.2 Global Bulk Drugs Market

4. Indian Bulk Drugs Market---- an Overview

4.1 Indian Pharmaceutical Market

4.2 Indian Bulk Drugs

4.3 Growth Trends

4.4 Future outlook

5. Growth Drivers

5.1 High Growth of Generics / Patent expiries

5.2 New Drug Developments

5.3 Contract Manufacturing

5.4 Overall Pharmaceutical Growth

5.5 Reduced Manufacturing cost

6. Industry Regulations

6.1 Budget measures

6.2 Policy changes

6.3 Regulatory Bodies

6.4 Pharmaceutical Policy-2002

6.5 National pharmaceutical policy 2006

6.6 Pricing of Scheduled Bulk Drugs

6.7 Indian Patent law

6.8 Labelling System in India

6.9 Intellectual Property Rights (IPR)

6.10 Trade Related Aspects of Intellectual Property Rights (TRIPS)

6.11 Bulk drugs prices come under NPPA lens

7. Issues & Challenges

7.1 Increasing Competition

7.2 Coping with Changing Disease Profile

7.3 Over Capacity

7.4 Undifferentiated Capabilities

7.5 Varying regulatory requirements lead to additional costs

7.6 Threat from China

8. Major Players

8.1 Aurobindo Pharma

8.2 Ranbaxy Laboratories

8.3 Dr. Reddy's Laboratories

8.4 Lupin Ltd

8.5 Matrix Laboratories

8.6 Cipla Ltd

8.7 Orchid Chemicals and Pharmaceuticals Ltd.

8.8 Divis laboratories

8.9 Sun Pharmaceutical Industries Ltd

8.10 Ipca Laboratories Ltd.

8.11 Dishman Pharmaceutical and Chemicals Ltd

8.12 Cadila Healthcare Ltd

8.13 Alembic Ltd

8.14. Glaxo SmithKline Pharmaceuticals Ltd.

8.15 Glenmark Pharmaceuticals Ltd.

8.16 Piramal Healthcare Limited (PHL)

8.17 Unichem Laboratories Ltd

8.18 Merck India Ltd.

8.19 Atul Ltd

9. Critical Success Factors

9.1 Low-Cost Manufacturing Skills

9.2 Striking Strategic Alliances (Mergers & Acquisitions)

9.3 Growing Experience with cGMP Compliance

9.4 Complex Synthesis Capabilities

9.5 Identifying New Opportunities Holds the Key for Generic Manufacturers

9.6 Indian Companies enter in to Global Cancer Drugs Market

9.7 Focus on New therapeutic Segments

9.8 Time the Market

9.9 Accreditations

10. Future Outlook

Annexure 1: List of Abbreviations

Annexure 2: DMF filings by Indian companies

Annexure 3: List of Bulk Drugs Manufacturers in India

Annexure 4: List of Industry Organizations

Annexure 5: Bibilography

List of Figures

Figure 3.1: Global pharmaceutical market value (2005-2009)

Figure 3.2: Global Market Share in % (2009)

Figure 3.3: Global Bulk Drugs Market Size (2006-10)

Figure 4.1: Indian Domestic Pharmaceutical Market

Figure 4.2: Major Therapeutic Segments as% Contribution (2008-09)

Figure 4.3: Vision 2010: Glimpse of Indian Pharmaceutical Market Future

Figure 4.4: Total Market Size (2004-09)

Figure 4.5: Exports Vs Exports (%) to total

Figure 4.6: Indian bulk drugs Imports

Figure 5.1: Global Contract Manufacturing Market

List of Tables

Table 1: Leading Therapeutic Segments


Table 2: Leading Brands


Table 3: Major Markets


Table 4: Market Segment (US$ bn)

Table 5: Global Major Players Table 6: Major Acquisition in 2005-10

Table 7: Annual Production of Major Bulk Drugs

Table 8: Major Deals Announced/Completed By Indian Companies

Table 9: ANDA Filings by Indian Companies

Table 10: R&D Expenditure


Table 11: DMF filings by Indian companies

Table 12: India's Advantages for Contract Manufacturing

Table 13: Comparison between India and China

To order this report:

Drug and Medication Industry: Indian Bulk Drug Market

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... l,immunothérapie au traitement photodynamique au Bremachlorin contre le ... nouvelle approche consistant à combiner l,immunothérapie au traitement ...    --> Une nouvelle approche ... Bremachlorin contre le cancer avancé.    ...
(Date:11/27/2015)... , November 27, 2015 ... set to go online. The potential to save costs, ... vast and far from fully exploited as yet. Here, ... health records, either via mobile tablet or directly at ... --> ) -->      ...
(Date:11/27/2015)... , Niederlande, November 27, 2015 ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... bei fortgeschrittenem Krebs.   --> ... bei fortgeschrittenem Krebs.   Clinical Cancer ... --> Clinical Cancer Research vom 6. ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at which ... age, more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions ... overworked. The forgotten part of this equation: 80 percent of medical care occurs ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a ... customers 10% off of their purchase of lice treatment product. In addition, customers will ... to a company spokesperson. “Finding lice is a sure way to ruin the holidays, ...
(Date:11/27/2015)... Fairfax, VVA (PRWEB) , ... November 27, 2015 ... ... (RBMA) motto of progress through sharing, the 2016 Building Better Radiology ... campaigns. The conference will begin on Sunday, March 6, 2016, at Caesars Palace ...
(Date:11/27/2015)... ... 27, 2015 , ... Keeping in mind challenges faced by ... wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for ... parents and bring advice from parenting experts within their reach. As a part ...
(Date:11/27/2015)... ... 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces ... This is one of Joplin's most famous and beautiful concert posters. The concert was ... in Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's ...
Breaking Medicine News(10 mins):